Pliant Therapeutics PLRX Stock Consolidating at 120 Next Move Ahead 20260521 Cramer Offers Strategic Insights on Market Moves and Undervalued Opportunities Vaxcyte PCVX Declines 059 Amid Market Weakness 20260521 Calisa ALIS Earnings Outlook Key Metrics for Q1 2026